BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Covington
Argus Health
Farmers Insurance
Medtronic
UBS
Mallinckrodt
Deloitte
Julphar
Queensland Health

Generated: January 22, 2018

DrugPatentWatch Database Preview

Gavis Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for GAVIS PHARMS, and what generic and branded alternatives to GAVIS PHARMS drugs are available?

GAVIS PHARMS has seven approved drugs.



Summary for Gavis Pharms
US Patents:0
Tradenames:7
Ingredients:7
NDAs:7

Drugs and US Patents for Gavis Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gavis Pharms NALOXONE HYDROCHLORIDE AND PENTAZOCINE HYDROCHLORIDE naloxone hydrochloride; pentazocine hydrochloride TABLET;ORAL 075735-001 Jul 11, 2001 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms ORPHENADRINE CITRATE orphenadrine citrate TABLET, EXTENDED RELEASE;ORAL 040284-001 Jun 19, 1998 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms Llc FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 206422-001 Sep 2, 2015 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms ACETAMINOPHEN AND PENTAZOCINE HYDROCHLORIDE acetaminophen; pentazocine hydrochloride TABLET;ORAL 076202-001 Aug 2, 2002 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms TRIMETHOBENZAMIDE HYDROCHLORIDE trimethobenzamide hydrochloride CAPSULE;ORAL 076546-001 Aug 20, 2003 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms QUINARETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 076374-003 Mar 31, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms NYSTATIN nystatin POWDER;TOPICAL 065138-001 Jul 23, 2004 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms QUINARETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 076374-001 Mar 31, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Gavis Pharms QUINARETIC hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 076374-002 Mar 31, 2004 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Citi
QuintilesIMS
US Army
Harvard Business School
Cipla
Johnson and Johnson
Mallinckrodt
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot